Related references
Note: Only part of the references are listed.Four prescribed Chinese herbal medicines provide renoprotection and survival benefit without hyperkalemia risk in patients with advanced chronic kidney disease: A nationwide cohort study
Yi-Chun Chen et al.
PHYTOMEDICINE (2022)
Treatment of Helicobacter pylori infection: A clinical practice update
Rocco Maurizio Zagari et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors
M. Venerito et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides
Einat Gorelik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Association between Helicobacter pylori eradication and the risk of coronary heart diseases
Jiunn-Wei Wang et al.
PLoS One (2018)
Increased risk of coronary heart disease among patients with primary Sjogren's syndrome: a nationwide population-based cohort study
Xue-Fen Wu et al.
SCIENTIFIC REPORTS (2018)
Association between Peptic Ulcer Disease and Periodontitis: A Nationwide Population-Based Case-Control Study in Taiwan
Hui-Chieh Yu et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
Long-Term Risk of Acute Myocardial Infarction, Stroke, and Death With Outpatient Use of Clarithromycin: A Retrospective Cohort Study
Andrew D. Mosholder et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Long-Term Risk of Cardiovascular Death With Use of Clarithromycin and Roxithromycin: A Nationwide Cohort Study
Malin Inghammar et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China
J. Jiang et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
P. Malfertheiner et al.
GUT (2017)
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
James K. Y. Hooi et al.
GASTROENTEROLOGY (2017)
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
Bor-Shyang Sheu et al.
HELICOBACTER (2017)
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy
Douglas F. Arbetter et al.
PHARMACEUTICAL STATISTICS (2017)
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study
Ellen Berni et al.
BMJ OPEN (2017)
Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs
Adrian A. Root et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Leukemia Risk After Cardiac Fluoroscopic Interventions Stratified by Procedure Number, Exposure Latent Time, and Sex A Nationwide Population-Based Case-Control Study
Kai-Che Wei et al.
MEDICINE (2016)
Cardiovascular outcomes associated with use of clarithromycin: population based study
Angel Y. S. Wong et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Cardiovascular outcomes associated with use of clarithromycin: population based study
Angel Y. S. Wong et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the CLARICOR randomised, blinded clinical trial
Per Winkel et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan
Yi-Chun Chen et al.
KIDNEY INTERNATIONAL (2015)
Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease - ECG-findings in a population-based cohort study
Ulf Nilsson et al.
BMC PULMONARY MEDICINE (2015)
A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease
Yi-Chun Chen et al.
KIDNEY INTERNATIONAL (2014)
Peptic Ulcer Disease Risk in Chronic Kidney Disease: Ten-Year Incidence, Ulcer Location, and Ulcerogenic Effect of Medications
Chih-Chia Liang et al.
PLOS ONE (2014)
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
Henrik Svanstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake
C. Charpignon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Helicobacter pylori infection in patients with nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Iron Status and Helicobacter pylori Infection in Symptomatic Children: An International Multi-Centered Study
Dulciene Maria Magalhaes Queiroz et al.
PLOS ONE (2013)
Association of heart diseases with COPD and restrictive lung function - Results from a population survey
Berne Eriksson et al.
RESPIRATORY MEDICINE (2013)
Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies
Stuart Schembri et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Cardiac Complications in Patients With Community-Acquired Pneumonia Incidence, Timing, Risk Factors, and Association With Short-Term Mortality
Vicente F. Corrales-Medina et al.
CIRCULATION (2012)
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Following Liver Resection
Chun-Ying Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan
Fu-Wei Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Clarithromycin Use and Risk of Death in Patients with Ischemic Heart Disease
Soren Skott Andersen et al.
CARDIOLOGY (2010)
Statin Treatment Prevents Increased Cardiovascular and All-Cause Mortality Associated With Clarithromycin in Patients With Stable Coronary Heart Disease
Gorm B. Jensen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial
CM Jespersen
BRITISH MEDICAL JOURNAL (2006)
Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers
SJ Konturek et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-Q-wave coronary syndrome
J Sinisalo et al.
CIRCULATION (2002)
Use of comorbidity scores for control of confounding in studies using administrative data bases
S Schneeweiss et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2000)
Share Paper
